Risperdal Lawsuits | $124M Verdict Upheld by Supreme Court
RISPERDAL: WHAT DOES THE $125 MILLION PENALTY AGAINST THE DRUGMAKER MEAN? Verdict Against Risperdal Drugmaker Upheld By U.S. Supreme Court The U.S. Supreme Court refused to hear an appeal from Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson and maker of the anti-psychotic drug, Risperdal, also known as risperidone. The company has been penalized $124 million by a South […]
Risperdal Linked to Gynecomastia
Martin Crump recently authored an eBook regarding Risperdal, a psychiatric medication marketed by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. The book discusses the history of Risperdal, Janssen’s Pharmaceuticals’ efforts to market the drug to minors, and Risperdal’s link to gynecomastia (enlarged male breasts). Janssen Pharmaceuticals obtained approval from the FDA in 1993 to […]
